217 related articles for article (PubMed ID: 18483258)
1. UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes.
He YY; Council SE; Feng L; Chignell CF
Cancer Res; 2008 May; 68(10):3752-8. PubMed ID: 18483258
[TBL] [Abstract][Full Text] [Related]
2. Requirement for metalloproteinase-dependent ERK and AKT activation in UVB-induced G1-S cell cycle progression of human keratinocytes.
Han W; He YY
Photochem Photobiol; 2009; 85(4):997-1003. PubMed ID: 19222789
[TBL] [Abstract][Full Text] [Related]
3. Delayed and sustained activation of extracellular signal-regulated kinase in human keratinocytes by UVA: implications in carcinogenesis.
He YY; Huang JL; Chignell CF
J Biol Chem; 2004 Dec; 279(51):53867-74. PubMed ID: 15471881
[TBL] [Abstract][Full Text] [Related]
4. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
[TBL] [Abstract][Full Text] [Related]
5. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor.
Iordanov MS; Choi RJ; Ryabinina OP; Dinh TH; Bright RK; Magun BE
Mol Cell Biol; 2002 Aug; 22(15):5380-94. PubMed ID: 12101233
[TBL] [Abstract][Full Text] [Related]
6. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib.
Matsuo M; Sakurai H; Ueno Y; Ohtani O; Saiki I
Cancer Sci; 2006 Feb; 97(2):155-62. PubMed ID: 16441427
[TBL] [Abstract][Full Text] [Related]
7. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.
Liu W; Ren H; Ren J; Yin T; Hu B; Xie S; Dai Y; Wu W; Xiao Z; Yang X; Xie D
Mediators Inflamm; 2013; 2013():651207. PubMed ID: 24311896
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway.
Lin P; Sun X; Feng T; Zou H; Jiang Y; Liu Z; Zhao D; Yu X
Mol Cell Biochem; 2012 Jan; 359(1-2):235-43. PubMed ID: 21837402
[TBL] [Abstract][Full Text] [Related]
9. Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.
Ansari KM; Rundhaug JE; Fischer SM
Mol Cancer Res; 2008 Jun; 6(6):1003-16. PubMed ID: 18567804
[TBL] [Abstract][Full Text] [Related]
10. Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16.
Bai T; Liu F; Zou F; Zhao G; Jiang Y; Liu L; Shi J; Hao D; Zhang Q; Zheng T; Zhang Y; Liu M; Li S; Qi L; Liu JY
Stem Cells Dev; 2017 Jan; 26(2):113-122. PubMed ID: 27702388
[TBL] [Abstract][Full Text] [Related]
11. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
Wang XJ; Feng CW; Li M
Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor down-regulation induced by UVA in human keratinocytes does not require the receptor kinase activity.
He YY; Huang JL; Gentry JB; Chignell CF
J Biol Chem; 2003 Oct; 278(43):42457-65. PubMed ID: 12930839
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.
Wu K; Wang C; D'Amico M; Lee RJ; Albanese C; Pestell RG; Mani S
Mol Cancer Ther; 2002 Jul; 1(9):695-706. PubMed ID: 12479366
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells.
Kilker RL; Planas-Silva MD
Cancer Res; 2006 Dec; 66(23):11478-84. PubMed ID: 17145896
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex.
Mairet-Coello G; Tury A; DiCicco-Bloom E
J Neurosci; 2009 Jan; 29(3):775-88. PubMed ID: 19158303
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes.
Wang HQ; Quan T; He T; Franke TF; Voorhees JJ; Fisher GJ
J Biol Chem; 2003 Nov; 278(46):45737-45. PubMed ID: 12952968
[TBL] [Abstract][Full Text] [Related]
17. EGFR-mediated Akt and MAPKs signal pathways play a crucial role in patulin-induced cell proliferation in primary murine keratinocytes via modulation of Cyclin D1 and COX-2 expression.
Alam S; Pal A; Kumar R; Dwivedi PD; Das M; Ansari KM
Mol Carcinog; 2014 Dec; 53(12):988-98. PubMed ID: 23813870
[TBL] [Abstract][Full Text] [Related]
18. PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.
Ouyang W; Luo W; Zhang D; Jian J; Ma Q; Li J; Shi X; Chen J; Gao J; Huang C
Environ Health Perspect; 2008 Jan; 116(1):1-6. PubMed ID: 18197291
[TBL] [Abstract][Full Text] [Related]
19. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
[TBL] [Abstract][Full Text] [Related]
20. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
